Literature DB >> 9785808

Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation.

R Pela1, F Marchesani, C Agostinelli, D Staccioli, L Cecarini, C Bassotti, C M Sanguinetti.   

Abstract

Patients affected with chronic obstructive pulmonary disease (COPD) undergo frequent exacerbations of their illness characterized by increased cough and expectoration. The precise aetiology of these episodes often remains unknown. In the absence of clinical or radiographic signs of pneumonia, bacterial or viral cultures of sputum usually provide little useful information. Thus, we performed fibreoptic bronchoscopy using a protected specimen brush (PSB) to obtain uncontaminated secretions for culture from 56 patients with COPD, 16 with stable clinical conditions and 40 affected with exacerbations of the disease. The aim of our study was to evaluate bronchial microbial flora by quantitative aerobic and anaerobic culture of each specimen. Twenty five subjects (45%), 4 (16%) in stable state and 21 (84%) with COPD exacerbations, had specimens which gave rise to significant bacterial growth (> 10(3) colony forming units.mL-1). The predominant bacteria were Streptococcus pneumoniae (in 10 cases) and alpha-haemolytic streptococci (in 6 cases); other bacteria found were coagulase-negative staphylococci and Branhamella catarralis in (2 cases each), and Proteus mirabilis, Haemophilus influenzae, Pseudomonas aeruginosa, Aerococcus viridans and Chromobacterium violaceum (each in a single case only). Although significant bacterial growth was more frequently found in patients with chronic obstructive pulmonary disease exacerbations and in those with a higher degree of bronchial inflammation, the differences between the two groups of patients were not statistically significant. Nevertheless, the results obtained in our study confirm the validity of and the need for reliable sampling methods (like the protected specimen brush) to demonstrate significant bacterial colonization of the airways in chronic obstructive pulmonary disease patients.

Entities:  

Mesh:

Year:  1998        PMID: 9785808

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  23 in total

Review 1.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

Review 2.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

3.  Significance of the microbiome in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; John R Erb-Downward; Gary B Huffnagle
Journal:  Ann Am Thorac Soc       Date:  2013-12

Review 4.  Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence.

Authors:  Ken M Kunisaki; Kathryn L Rice; Dennis E Niewoehner
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

5.  Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis.

Authors:  R Wilson; P Jones; T Schaberg; P Arvis; I Duprat-Lomon; P P Sagnier
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

Review 6.  Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-12

Review 7.  Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management.

Authors:  Don Hayes; Keith C Meyer
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 8.  Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient.

Authors:  Timothy F Murphy; Sanjay Sethi
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

9.  The Role of Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Sanjay Sethi
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

Review 10.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.